126 related articles for article (PubMed ID: 22898593)
1. Intracoronary infusion of bone marrow-derived mononuclear cells contributes to longstanding improvements of left ventricular performance and remodelling after acute myocardial infarction: a meta-analysis.
Ye Z; Zhang BL; Zhao XX; Qin YW; Wu H; Cao J; Zhang JL; Hu JQ; Zheng X; Xu RL
Heart Lung Circ; 2012 Nov; 21(11):725-33. PubMed ID: 22898593
[TBL] [Abstract][Full Text] [Related]
2. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial.
Hirsch A; Nijveldt R; van der Vleuten PA; Tijssen JG; van der Giessen WJ; Tio RA; Waltenberger J; ten Berg JM; Doevendans PA; Aengevaeren WR; Zwaginga JJ; Biemond BJ; van Rossum AC; Piek JJ; Zijlstra F;
Eur Heart J; 2011 Jul; 32(14):1736-47. PubMed ID: 21148540
[TBL] [Abstract][Full Text] [Related]
3. Intracoronary autologous bone marrow stem cells transfer for patients with acute myocardial infarction: a meta-analysis of randomised controlled trials.
Zhang SN; Sun AJ; Ge JB; Yao K; Huang ZY; Wang KQ; Zou YZ
Int J Cardiol; 2009 Aug; 136(2):178-85. PubMed ID: 18644638
[TBL] [Abstract][Full Text] [Related]
4. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a meta-analysis of randomised controlled clinical trials.
Delewi R; Andriessen A; Tijssen JG; Zijlstra F; Piek JJ; Hirsch A
Heart; 2013 Feb; 99(4):225-32. PubMed ID: 22875736
[TBL] [Abstract][Full Text] [Related]
5. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
[TBL] [Abstract][Full Text] [Related]
6. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial.
Tendera M; Wojakowski W; Ruzyłło W; Chojnowska L; Kepka C; Tracz W; Musiałek P; Piwowarska W; Nessler J; Buszman P; Grajek S; Breborowicz P; Majka M; Ratajczak MZ;
Eur Heart J; 2009 Jun; 30(11):1313-21. PubMed ID: 19208649
[TBL] [Abstract][Full Text] [Related]
7. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.
Lunde K; Solheim S; Aakhus S; Arnesen H; Abdelnoor M; Egeland T; Endresen K; Ilebekk A; Mangschau A; Fjeld JG; Smith HJ; Taraldsrud E; Grøgaard HK; Bjørnerheim R; Brekke M; Müller C; Hopp E; Ragnarsson A; Brinchmann JE; Forfang K
N Engl J Med; 2006 Sep; 355(12):1199-209. PubMed ID: 16990383
[TBL] [Abstract][Full Text] [Related]
8. [Long term follow-up on emergent intracoronary autologous bone marrow mononuclear cell transplantation for acute inferior-wall myocardial infarction].
Huang RC; Yao K; Zou YZ; Ge L; Qian JY; Yang J; Yang S; Niu YH; Li YL; Zhang YQ; Zhang F; Xu SK; Zhang SH; Sun AJ; Ge JB
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1107-10. PubMed ID: 16796836
[TBL] [Abstract][Full Text] [Related]
9. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.
Hirsch A; Nijveldt R; van der Vleuten PA; Biemond BJ; Doevendans PA; van Rossum AC; Tijssen JG; Zijlstra F; Piek JJ;
Am Heart J; 2006 Sep; 152(3):434-41. PubMed ID: 16923409
[TBL] [Abstract][Full Text] [Related]
10. Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging.
Traverse JH; Henry TD; Moye' LA
Am Heart J; 2011 Oct; 162(4):671-7. PubMed ID: 21982659
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: a meta-analysis of randomized controlled trials.
Kang S; Yang Y; Li CJ; Gao R
Clin Ther; 2007 Nov; 29(11):2406-18. PubMed ID: 18158081
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
Singh M; Shah T; Khosla K; Singh P; Molnar J; Khosla S; Arora R
Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):101-14. PubMed ID: 22562999
[TBL] [Abstract][Full Text] [Related]
13. Bone-marrow-derived cell transfer after ST-elevation myocardial infarction: lessons from the BOOST trial.
Drexler H; Meyer GP; Wollert KC
Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S65-8. PubMed ID: 16501634
[TBL] [Abstract][Full Text] [Related]
14. Effects of timing on intracoronary autologous bone marrow-derived cell transplantation in acute myocardial infarction: a meta-analysis of randomized controlled trials.
Xu JY; Liu D; Zhong Y; Huang RC
Stem Cell Res Ther; 2017 Oct; 8(1):231. PubMed ID: 29037256
[TBL] [Abstract][Full Text] [Related]
15. Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function.
Yao K; Huang R; Qian J; Cui J; Ge L; Li Y; Zhang F; Shi H; Huang D; Zhang S; Sun A; Zou Y; Ge J
Heart; 2008 Sep; 94(9):1147-53. PubMed ID: 18381377
[TBL] [Abstract][Full Text] [Related]
16. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.
Meyer GP; Wollert KC; Lotz J; Steffens J; Lippolt P; Fichtner S; Hecker H; Schaefer A; Arseniev L; Hertenstein B; Ganser A; Drexler H
Circulation; 2006 Mar; 113(10):1287-94. PubMed ID: 16520413
[TBL] [Abstract][Full Text] [Related]
17. Intracoronary infusion of bone marrow-derived mononuclear cells abrogates adverse left ventricular remodelling post-acute myocardial infarction: insights from the reinfusion of enriched progenitor cells and infarct remodelling in acute myocardial infarction (REPAIR-AMI) trial.
Schächinger V; Assmus B; Erbs S; Elsässer A; Haberbosch W; Hambrecht R; Yu J; Corti R; Mathey DG; Hamm CW; Tonn T; Dimmeler S; Zeiher AM;
Eur J Heart Fail; 2009 Oct; 11(10):973-9. PubMed ID: 19789401
[TBL] [Abstract][Full Text] [Related]
18. Bone Marrow Mononuclear Cells Transfer for Patients after ST-Elevated Myocardial Infarction: A Meta-Analysis of Randomized Control Trials.
Zhang J; Lin L; Zong W
Yonsei Med J; 2018 Jul; 59(5):611-623. PubMed ID: 29869459
[TBL] [Abstract][Full Text] [Related]
19. [Cardiomyoplasty with autological mononuclear cells of the bone marrow in patients with acute myocardial infarction].
Riabov VV; Suslova TE; Krylov AL; Poponina IuS; Vesnina ZhV; Sazonova SI; Markov VA; Popov SV; Karpov RS
Ter Arkh; 2006; 78(8):47-52. PubMed ID: 17078217
[TBL] [Abstract][Full Text] [Related]
20. Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial.
Schaefer A; Meyer GP; Fuchs M; Klein G; Kaplan M; Wollert KC; Drexler H
Eur Heart J; 2006 Apr; 27(8):929-35. PubMed ID: 16510465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
